Used in research and development for targeting platelet-derived growth factor B (PDGFB) signaling pathways, this antibody helps investigate conditions involving abnormal cell proliferation and angiogenesis. It is applied in studies related to fibrosis, diabetic nephropathy, and certain cancers where PDGFB overexpression plays a role. Due to its high specificity, it serves as a reference tool for characterizing PDGFB function, validating assay systems, and supporting the development of therapeutic antibodies. It is also utilized in immunohistochemistry, neutralization assays, and pharmacokinetic studies during preclinical evaluation.